Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Altimmune, Biodexa, Chromadex, Eli Lilly, Entrada, G1, Mannkind, Novo, Poltreg, Regulus, Revelation, Sun, Takeda, Tiumbio.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Clover, Carsgen, Daewoong, Hightide, Hutchmed, Takeda.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aphaia, Atai, Cessation, Gilead, Janssen, Jazz, Kiromic, Mendus, PTC, Silence, Vaxxinity.